| 3-D Tumor Model for In Vitro Evaluation of Anticancer Drugs JL Horning, SK Sahoo, S Vijayaraghavalu, S Dimitrijevic, JK Vasir, ... Molecular pharmaceutics 5 (5), 849-862, 2008 | 396 | 2008 |
| Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles C Peetla, S Vijayaraghavalu, V Labhasetwar Advanced drug delivery reviews 65 (13-14), 1686-1698, 2013 | 260 | 2013 |
| Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids C Peetla, R Bhave, S Vijayaraghavalu, A Stine, E Kooijman, ... Molecular pharmaceutics 7 (6), 2334-2348, 2010 | 143 | 2010 |
| Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene … S Vijayaraghavalu, JK Dermawan, V Cheriyath, V Labhasetwar Molecular pharmaceutics 10 (1), 337-352, 2013 | 101 | 2013 |
| Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions S Vijayaraghavalu, C Peetla, S Lu, V Labhasetwar Molecular pharmaceutics 9 (9), 2730-2742, 2012 | 74 | 2012 |
| Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis V Perumal, PM Sivakumar, A Zarrabi, S Muthupandian, S Vijayaraghavalu, ... Journal of Photochemistry and Photobiology B: Biology 199, 111630, 2019 | 51 | 2019 |
| Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion S Vijayaraghavalu, V Labhasetwar Cancer letters 331 (1), 122-129, 2013 | 46 | 2013 |
| Nanoparticles for delivery of chemotherapeutic agents to tumors. S Vijayaraghavalu, D Raghavan, V Labhasetwar Current opinion in investigational drugs (London, England: 2000) 8 (6), 477-484, 2007 | 39 | 2007 |
| In vivo micronucleus assay and GST activity in assessing genotoxicity of plumbagin in Swiss albino mice S Vijayaraghavalu, R Prakash, MR Murali, H Devaraj, S Niranjali Devaraj Drug and chemical toxicology 28 (4), 499-507, 2005 | 36 | 2005 |
| Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury Y Gao, S Vijayaraghavalu, M Stees, BK Kwon, V Labhasetwar Journal of controlled release 302, 160-168, 2019 | 34 | 2019 |
| Protective effect of Plumbago zeylanica against cyclophosphamide-induced genotoxicity and oxidative stress in Swiss albino mice S Vijayaraghavalu, S Niranjali Devaraj Drug and chemical toxicology 29 (3), 279-288, 2006 | 34 | 2006 |
| An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients R Ravichandran, SK Mohan, SK Sukumaran, D Kamaraj, SS Daivasuga, ... Scientific reports 12 (1), 1-10, 2022 | 29 | 2022 |
| Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis S Vijayaraghavalu, Y Gao, MT Rahman, R Rozic, N Sharifi, RJ Midura, ... Biomaterials 227, 119558, 2020 | 26 | 2020 |
| Synthesis, characterization and antiproliferative activity of rapamycin-loaded poly (N-isopropylacrylamide)-based nanogels in vascular smooth muscle cells MM Yallapu, JK Vasir, TK Jain, S Vijayaraghavalu, V Labhasetwar Journal of biomedical nanotechnology 4 (1), 16-24, 2008 | 25 | 2008 |
| Genetic Polymorphisms of Xenobiotic Metabolizing Genes (GSTM1, GSTT1, GSTP1), Gene-Gene Interaction with Association to Lung Cancer Risk in North India; A Case Control Study. M Ritambhara, Tiwari, S., Vijayaraghavalu, S., Kumar Asian Pacific Journal of Cancer Prevention. 2019, 20(9), 2707-2714. 20 (9 …, 2019 | 20* | 2019 |
| Sustained Epigenetic Drug Delivery Depletes Cholesterol–Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids S Vijayaraghavalu, V Raghavan, C Peetla, M Yamada, M Morisada, and V Labhasetwar Langmuir, 2015 | 19 | 2015 |
| Recent advances targeting innate immunity‐mediated therapies against HIV‐1 infection EM Shankar, V Velu, R Vignesh, S Vijayaraghavalu, DV Rukumani, ... Microbiology and immunology 56 (8), 497-505, 2012 | 19 | 2012 |
| Arginine-modified polymers facilitate poly (lactide-co-glycolide)-based nanoparticle gene delivery to primary human astrocytes J Proulx, C Joshi, S Vijayaraghavalu, M Saraswathy, V Labhasetwar, ... International journal of nanomedicine, 3639-3647, 2020 | 18 | 2020 |
| Treatment and Recycling of wastewater from dairy industry Ritambhara, Zainab, S Vijayaraghavalu, HK Prasad, M Kumar Advances in Biological Treatment of Industrial Waste Water and their …, 2019 | 18 | 2019 |
| Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells S Vijayaraghavalu, V Labhasetwar Drug delivery and translational research 8, 1289-1299, 2018 | 17 | 2018 |
Vinod Labhasetwar, Ph.D.Professor, Biomedical Engineering, Lerner Research Institute, Cleveland ClinicVerified email at ccf.org
